Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

× No keyword cloud information.

85 in total

1. Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

Authors: Susan B Brogly; Mark J Abzug; D Heather Watts; Coleen K Cunningham; Paige L Williams; James Oleske; Daniel Conway; Rhoda S Sperling; Hans Spiegel; Russell B Van Dyke
Journal: Pediatr Infect Dis J Date: 2010-08 Impact factor: 2.129

2. Perinatal exposure to antiretroviral agents: risks and benefits.

Authors: Gwendolyn B Scott
Journal: AJNR Am J Neuroradiol Date: 2005-04 Impact factor: 3.825

3. Effect of antiretroviral agents on triglyceride levels in HIV-1-infected pregnant women.

Authors: Patrícia El-Beitune; Geraldo Duarte; José Ernesto dos Santos
Journal: Lipids Date: 2006-04 Impact factor: 1.880

4. Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor-susceptible human immunodeficiency virus type 1.

Authors: Jörn Lötsch; Sebastian Harder; Martin Stürmer; Hans-Wilhelm Doerr; Gerd Geisslinger; Schlomo Staszewski; Nils von Hentig
Journal: Antimicrob Agents Chemother Date: 2007-06-18 Impact factor: 5.191

Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

1. Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

2. Perinatal exposure to antiretroviral agents: risks and benefits.

3. Effect of antiretroviral agents on triglyceride levels in HIV-1-infected pregnant women.

4. Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor-susceptible human immunodeficiency virus type 1.

5. Hepatitis C Virus Screening Among Children Exposed During Pregnancy.

6. Progress and Emerging Challenges in Preventing Mother-to-Child Transmission.

Review 7. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

8. Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelines.

Review 9. Raltegravir use in special populations.

10. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.